Across TCGA pan-cancer cohorts, USP48 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated USP48 data layer compared with 26 for mass-spec protein and 6 for mutation status.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher USP48 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated USP48 expression acts as an unfavorable survival marker, although some lineages such as LSCC and PDAC show a favorable association.
COAD, UCEC, and HNSC are the cancer types where USP48 mass-spec protein most reproducibly stratifies survival.